EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sequencing Immunotherapy and Hypofractionated Radiotherapy in Frail Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma

Beatrice Bettazzi, Viola Salvestrini iD, Marco Banini iD, Olga Ruggieri, Annarita Palomba, Ilaria Camilla Galli, Lorenzo Livi, Pierluigi Bonomo iD, Carlotta Becherini

Current Oncology · 22.04.2026 · 33 (5) · 239

DOI: 10.3390/curroncol33050239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, online erschienen am 22.04.2026. Verfasst von Beatrice Bettazzi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Biomedical Sciences M. Serio, University of Florence, 50134 Florence, Italy. Hauptthemen laut MEDLINE: Squamous Cell Carcinoma of Head and Neck, Immunotherapy, Radiation Dose Hypofractionation, Head and Neck Neoplasms. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1)

Background

Hypofractionated radiotherapy and immunotherapy (IT) are possible treatment options for HNSCC patients unsuitable for standard curative treatment, yet no high-level evidence supports their combined use. We aim to report on the clinical outcome of a single-center cohort of HNSCC patients treated with a hypofractionated radiotherapy (hypoRT) regimen in combination with IT alone or chemo-immunotherapy (CT-IT). (2)

Methods

We enrolled a cohort of elderly and frail HNSCC patients unsuitable for standard curative treatment, deemed candidates to undergo hypoRT in a sequential strategy (time interval < 6 months), followed or preceded by IT alone (hypoRT_IT) or CT-IT. We selected our sample using the Geriatric 8 (G8) score and the Charlson Comorbidity Index (CCI). (3)

Results

At a median follow-up of 11 months (IQR 5–20), the median locoregional control (LRC) was 12 months (95% CI 7.0–17.1) with a 1-year progression-free survival rate of 63%. For the hypoRT-IT group, the median overall survival was 12 months (95% CI 0–24). No grade (G) 4–5 in-field acute side effects were observed, while one case of G3 oral mucositis and two cases of G3 radiation dermatitis were reported. (4)

Conclusions

A sequential combination of checkpoint inhibitors and hypoRT may provide clinical benefit with acceptable toxicity in frail and elderly patients with advanced HNSCC unfit for standard therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Squamous Cell Carcinoma of Head and NeckImmunotherapyRadiation Dose HypofractionationHead and Neck NeoplasmsHumansFemaleMaleAgedAged, 80 and overFrail ElderlyCombined Modality Therapy

Stichwörter der Autor:innen

HNSCCelderlyfrailhypofractionatedimmunotherapylocoregional controlradiotherapysequenceunfit

Autor:innen und Institutionen

  • Department of Experimental and Clinical Biomedical Sciences M. Serio, University of Florence, 50134 Florence, Italy.
  • Department of Radiation Oncology, Careggi University Hospital, 50134 Florence, Italy.
  • Istituto Fiorentino di Cura e Assistenza (IFCA), 50139 Florence, Italy.
  • Histopathology and Molecular Diagnostics, Careggi University Hospital, 50134 Florence, Italy.

ORCID-Profile: Viola Salvestrini, Marco Banini, Pierluigi Bonomo

Zitieren

APA

Bettazzi, B., Salvestrini, V., Banini, M., Ruggieri, O., Palomba, A., Galli, I. C., Livi, L., Bonomo, P., & Becherini, C. (2026). Sequencing Immunotherapy and Hypofractionated Radiotherapy in Frail Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma. Current Oncology, 33(5), 239. https://doi.org/10.3390/curroncol33050239

Vancouver

Bettazzi B, Salvestrini V, Banini M, Ruggieri O, Palomba A, Galli IC, et al. Sequencing Immunotherapy and Hypofractionated Radiotherapy in Frail Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma. Current Oncology. 2026;33(5):239. doi:10.3390/curroncol33050239

BibTeX
@article{Bettazzi2026,
  author = {Bettazzi, Beatrice and Salvestrini, Viola and Banini, Marco and Ruggieri, Olga and Palomba, Annarita and Galli, Ilaria Camilla and Livi, Lorenzo and Bonomo, Pierluigi and Becherini, Carlotta},
  title = {Sequencing Immunotherapy and Hypofractionated Radiotherapy in Frail Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma},
  journal = {Current Oncology},
  year = {2026},
  volume = {33},
  number = {5},
  pages = {239},
  doi = {10.3390/curroncol33050239}
}
Kostenlos starten →